Know Your IPO: Snowflake, GW Pharmaceuticals CEO & Stocks Moving On Vaccine News
The Dow started the week, closing up 328 points and Jim Cramer's breaking down today's headlines and getting investors ready for the trading week ahead. Then, as the long-awaited IPO Snowflake comes public this week, Cramer is taking a closer look at the company and making sense of what to do with the stock. Then, GW Pharmaceuticals CEO Justin Gover checks in to break down the company's most recent quarter. Plus, how could vaccine hopes be impacting the market each day? Cramer's breaking down all the stocks that are moving the most on headlines for a COVID treatment.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The Dow started the week, closing up 328 points and Jim Cramer's breaking down today's headlines and getting investors ready for the trading week ahead. Then, as the long-awaited IPO Snowflake comes public this week, Cramer is taking a closer look at the company and making sense of what to do with the stock. Then, GW Pharmaceuticals CEO Justin Gover checks in to break down the company's most recent quarter. Plus, how could vaccine hopes be impacting the market each day? Cramer's breaking down all the stocks that are moving the most on headlines for a COVID treatment.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.